サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1285897

間葉系幹細胞（MSC）市場 - 世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Mesenchymal Stem Cells Market (Products & Services: Product & Services; Source of Isolation: Bone Marrow, Adipose, Cord Blood, Peripheral Blood, Dental Pulp, & Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 237 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
間葉系幹細胞（MSC）市場 - 世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年
出版日: 2023年04月30日
発行: Transparency Market Research
ページ情報: 英文 237 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

間葉系幹細胞（MSC）市場 - レポートの範囲

世界の間葉系幹細胞（MSC）市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。レポートは、2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の世界の間葉系幹細胞（MSC）市場の収益を提供します。レポートは、2023年から2031年までの世界の間葉系幹細胞（MSC）市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、間葉系幹細胞（MSC）市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書を参照することが含まれます。

このレポートは、世界の間葉系幹細胞（MSC）市場の競合情勢を詳しく掘り下げています。世界の間葉系幹細胞（MSC）市場で活動している主要企業が特定され、さまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、およびSWOTは、このレポートで紹介されている世界の間葉系幹細胞（MSC）市場の企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • パイプライン分析
  • 主な研究機関一覧
  • さまざまな疾患の現在の動向と将来の見通し
  • 地域別/世界全体の規制シナリオ
  • COVID-19パンデミックによる業界への影響

第6章 世界市場の分析と予測：製品・サービス別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測：製品・サービス別、2017-2031
    • 製品
      • ワークフロータイプ
      • 製品タイプ
    • サービス
  • 市場魅力度分析：製品・サービス別

第7章 世界市場の分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測：タイプ別、2017-2031
    • 自己由来
    • 同種異系
  • 市場魅力度分析：タイプ別

第8章 世界市場の分析と予測：分離源別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測：分離源別、2017-2031
    • 骨髄
      • 脂肪
      • 臍帯血
      • 末梢血
    • 歯髄
    • その他（肺組織、臍帯組織など）
  • 市場魅力分析：分離源別

第9章 世界市場の分析と予測：適応症別

  • イントロダクションと定義
  • 主な調査結果と開発
  • 市場金額予測：適応症別、2017-2031
    • 筋骨格系疾患
    • 心血管疾患
    • 神経障害
    • 自己免疫疾患
    • がん
    • GvHD
    • 肺疾患
    • その他
  • 市場魅力度分析：適応症別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第11章 北米市場の分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場金額予測：製品・サービス別、2017-2031
    • 製品
      • ワークフロータイプ
      • 製品タイプ
    • サービス
  • 市場金額予測：タイプ別、2017-2031
    • 自己由来
    • 同種異系
  • 市場金額予測：分離源別、2017-2031
    • 骨髄
      • 脂肪
      • 臍帯血
      • 末梢血
    • 歯髄
    • その他（肺組織、臍帯組織など）
  • 市場金額予測：適応症別、2017-2031
    • 筋骨格系疾患
    • 心血管疾患
    • 神経障害
    • 自己免疫疾患
    • がん
    • GvHD
    • 肺疾患
    • その他
  • 市場金額予測：国別、2017-2031
    • 米国
    • カナダ
  • 市場魅力分析
    • 製品別
    • タイプ別
    • 分離源別
    • 適応症別
    • 国別

第12章 欧州市場の分析と予測

  • イントロダクション
  • 市場金額予測：製品・サービス別、2017-2031
  • 市場金額予測：タイプ別、2017-2031
  • 市場金額予測：分離源別、2017-2031
  • 市場金額予測：適応症別、2017-2031
  • 市場金額予測：国別/サブリージョン別、2017-2031
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 市場魅力分析

第13章 アジア太平洋市場の分析と予測

  • イントロダクション
  • 市場金額予測：製品・サービス別、2017-2031
  • 市場金額予測：タイプ別、2017-2031
  • 市場金額予測：分離源別、2017-2031
  • 市場金額予測：適応症別、2017-2031
  • 市場金額予測：国別/サブリージョン別、2017-2031
    • 中国
    • 日本
    • インド
    • 韓国
    • その他アジア太平洋
  • 市場魅力分析

第14章 ラテンアメリカ市場の分析と予測

  • イントロダクション
  • 市場金額予測：製品・サービス別、2017-2031
  • 市場金額予測：タイプ別、2017-2031
  • 市場金額予測：分離源別、2017-2031
  • 市場金額予測：適応症別、2017-2031
  • 市場金額予測：国別/サブリージョン別、2017-2031
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 市場魅力分析

第15章 中東・アフリカ市場の分析と予測

  • イントロダクション
  • 市場金額予測：製品・サービス別、2017-2031
  • 市場金額予測：タイプ別、2017-2031
  • 市場金額予測：分離源別、2017-2031
  • 市場金額予測：適応症別、2017-2031
  • 市場金額予測：国別/サブリージョン別、2017-2031
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ
  • 市場魅力分析

第16章 競合情勢

  • 市場企業 - 競合マトリックス（ティア・企業規模別）
  • 市場シェア分析：企業別、2021年
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Cytiva（Danaher Corporation）
    • FUJIFILM Irvine Scientific（FUJIFILM Corporation）
    • Merck KGaA
    • Lonza Group Ltd.
    • STEMCELL Technologies, Inc.
    • Takara Bio, Inc.
    • Sartorius AG
    • Miltenyi Biotec GmbH
    • PromoCell GmbH
図表

List of Tables

  • Table 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 02: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 03: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 04: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2032
  • Table 05: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 06: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Region, 2017-2032
  • Table 07: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country, 2017-2032
  • Table 08: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 09: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 10: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 11: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 12: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 13: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 14: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 15: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 16: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 17: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 18: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 19: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 20: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 21: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 22: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 23: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 24: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 25: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 26: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 27: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 28: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 29: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 30: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 31: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 32: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 33: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 34: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 35: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 36: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032

List of Figures

  • Figure 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 02: Global Mesenchymal Stem Cells Market Value Share, by Products & Services, 2022
  • Figure 03: Global Mesenchymal Stem Cells Market Value Share, by Type, 2022
  • Figure 04: Global Mesenchymal Stem Cells Market Value Share, by Source of Isolation, 2022
  • Figure 05: Global Mesenchymal Stem Cells Market Value Share, by Indication, 2022
  • Figure 06: Global Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 07: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 08: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Product, 2017-2032
  • Figure 09: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Services, 2017-2032
  • Figure 10: Global Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 11: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 12: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Autologous, 2017-2032
  • Figure 13: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Allogenic, 2017-2032
  • Figure 14: Global Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 15: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 16: Global Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 17: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023-2032
  • Figure 18: Global Mesenchymal Stem Cells Market Value Share Analysis, by Region, 2022 and 2032
  • Figure 19: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Region, 2023-2032
  • Figure 20: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 21: North America Mesenchymal Stem Cells Market Value Share Analysis, by Country, 2022 and 2032
  • Figure 22: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country, 2023-2032
  • Figure 23: North America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 24: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 25: North America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 26: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 27: North America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 28: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 29: North America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 30: North America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 31: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 32: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 33: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 34: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 35: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 36: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 37: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 38: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 39: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 40: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 41: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 42: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 43: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 44: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 45: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 46: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 47: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 48: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 49: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 50: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 51: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 52: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 53: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 54: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 55: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 56: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 57: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 58: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 59: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Type, 2023-2032
  • Figure 60: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 61: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Source of Isolation, 2023-2032
  • Figure 62: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 63: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 64: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 65: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 66: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 67: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 68: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 69: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 70: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 71: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 72: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation, 2023-2032
  • Figure 73: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 74: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023-2032
目次
Product Code: TMRGL26735

Mesenchymal Stem Cells Market - Scope of Report

TMR's report on the global Mesenchymal Stem Cells Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Mesenchymal Stem Cells Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Mesenchymal Stem Cells Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Mesenchymal Stem Cells market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Mesenchymal Stem Cells market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Mesenchymal Stem Cells market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Mesenchymal Stem Cells market.

The report delves into the competitive landscape of the global Mesenchymal Stem Cells market. Key players operating in the global Mesenchymal Stem Cells Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Mesenchymal Stem Cells Market profiled in this report.

Key Questions Answered in Global Mesenchymal Stem Cells Market Report:

  • What is the sales/revenue generated by Mesenchymal Stem Cells across all regions during the forecast period?
  • What are the opportunities in the global Mesenchymal Stem Cells market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Mesenchymal Stem Cells Market - Research Objectives and Research Approach

The comprehensive report on the global Mesenchymal Stem Cells Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Mesenchymal Stem Cells Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Mesenchymal Stem Cells market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mesenchymal Stem Cells Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Mesenchymal Stem Cells Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List Of Major Research Institutes Involved In Mesenchymal Stem Cells Studies
  • 5.3. Mesenchymal Stem Cells: Current Trends and Future Prospects in a Variety of Disease Conditions
  • 5.4. Regulatory Scenario by Region/globally
  • 5.5. COVID-19 Pandemic Impact on Industry

6. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Products & Services

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Products & Services, 2017-2031
    • 6.3.1. Product
      • 6.3.1.1. Workflow Type
      • 6.3.1.2. Product Type
    • 6.3.2. Services
  • 6.4. Market Attractiveness Analysis, by Products & Services

7. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Type, 2017-2031
    • 7.3.1. Autologous
    • 7.3.2. Allogenic
  • 7.4. Market Attractiveness Analysis, by Type

8. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Source of Isolation

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Source of Isolation, 2017-2031
    • 8.3.1. Bone Marrow
      • 8.3.1.1. Adipose
      • 8.3.1.2. Cord Blood
      • 8.3.1.3. Peripheral Blood
    • 8.3.2. Dental Pulp
    • 8.3.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 8.4. Market Attractiveness Analysis, by Source of Isolation

9. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Musculoskeletal Diseases
    • 9.3.2. Cardiovascular Diseases
    • 9.3.3. Neuro Disorders
    • 9.3.4. Autoimmune Diseases
    • 9.3.5. Cancer
    • 9.3.6. GvHD
    • 9.3.7. Pulmonary Diseases
    • 9.3.8. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Mesenchymal Stem Cells Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Products & Services, 2017-2031
    • 11.2.1. Product
      • 11.2.1.1. Workflow Type
      • 11.2.1.2. Product Type
    • 11.2.2. Services
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Autologous
    • 11.3.2. Allogenic
  • 11.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 11.4.1. Bone Marrow
      • 11.4.1.1. Adipose
      • 11.4.1.2. Cord Blood
      • 11.4.1.3. Peripheral Blood
    • 11.4.2. Dental Pulp
    • 11.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 11.5. Market Value Forecast, by Indication , 2017-2031
    • 11.5.1. Musculoskeletal Diseases
    • 11.5.2. Cardiovascular Diseases
    • 11.5.3. Neuro Disorders
    • 11.5.4. Autoimmune Diseases
    • 11.5.5. Cancer
    • 11.5.6. GvHD
    • 11.5.7. Pulmonary Diseases
    • 11.5.8. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Type
    • 11.7.3. By Source of Isolation
    • 11.7.4. By Indication
    • 11.7.5. By Country

12. Europe Mesenchymal Stem Cells Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Products & Services, 2017-2031
    • 12.2.1. Product
      • 12.2.1.1. Workflow Type
      • 12.2.1.2. Product Type
    • 12.2.2. Services
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Autologous
    • 12.3.2. Allogenic
  • 12.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 12.4.1. Bone Marrow
      • 12.4.1.1. Adipose
      • 12.4.1.2. Cord Blood
      • 12.4.1.3. Peripheral Blood
    • 12.4.2. Dental Pulp
    • 12.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 12.5. Market Value Forecast, by Indication , 2017-2031
    • 12.5.1. Musculoskeletal Diseases
    • 12.5.2. Cardiovascular Diseases
    • 12.5.3. Neuro Disorders
    • 12.5.4. Autoimmune Diseases
    • 12.5.5. Cancer
    • 12.5.6. GvHD
    • 12.5.7. Pulmonary Diseases
    • 12.5.8. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Type
    • 12.7.3. By Source of Isolation
    • 12.7.4. By Indication
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Products & Services, 2017-2031
    • 13.2.1. Product
      • 13.2.1.1. Workflow Type
      • 13.2.1.2. Product Type
    • 13.2.2. Services
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Autologous
    • 13.3.2. Allogenic
  • 13.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 13.4.1. Bone Marrow
      • 13.4.1.1. Adipose
      • 13.4.1.2. Cord Blood
      • 13.4.1.3. Peripheral Blood
    • 13.4.2. Dental Pulp
    • 13.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 13.5. Market Value Forecast, by Indication , 2017-2031
    • 13.5.1. Musculoskeletal Diseases
    • 13.5.2. Cardiovascular Diseases
    • 13.5.3. Neuro Disorders
    • 13.5.4. Autoimmune Diseases
    • 13.5.5. Cancer
    • 13.5.6. GvHD
    • 13.5.7. Pulmonary Diseases
    • 13.5.8. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. South Korea
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Type
    • 13.7.3. By Source of Isolation
    • 13.7.4. By Indication
    • 13.7.5. By Country/Sub-region

14. Latin America Mesenchymal Stem Cells Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Products & Services, 2017-2031
    • 14.2.1. Product
      • 14.2.1.1. Workflow Type
      • 14.2.1.2. Product Type
    • 14.2.2. Services
  • 14.3. Market Value Forecast, by Type, 2017-2031
    • 14.3.1. Autologous
    • 14.3.2. Allogenic
  • 14.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 14.4.1. Bone Marrow
      • 14.4.1.1. Adipose
      • 14.4.1.2. Cord Blood
      • 14.4.1.3. Peripheral Blood
    • 14.4.2. Dental Pulp
    • 14.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 14.5. Market Value Forecast, by Indication , 2017-2031
    • 14.5.1. Musculoskeletal Diseases
    • 14.5.2. Cardiovascular Diseases
    • 14.5.3. Neuro Disorders
    • 14.5.4. Autoimmune Diseases
    • 14.5.5. Cancer
    • 14.5.6. GvHD
    • 14.5.7. Pulmonary Diseases
    • 14.5.8. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Type
    • 14.7.3. By Source of Isolation
    • 14.7.4. By Indication
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Mesenchymal Stem Cells Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Products & Services, 2017-2031
    • 15.2.1. Product
      • 15.2.1.1. Workflow Type
      • 15.2.1.2. Product Type
    • 15.2.2. Services
  • 15.3. Market Value Forecast, by Type, 2017-2031
    • 15.3.1. Autologous
    • 15.3.2. Allogenic
  • 15.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 15.4.1. Bone Marrow
      • 15.4.1.1. Adipose
      • 15.4.1.2. Cord Blood
      • 15.4.1.3. Peripheral Blood
    • 15.4.2. Dental Pulp
    • 15.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Musculoskeletal Diseases
    • 15.5.2. Cardiovascular Diseases
    • 15.5.3. Neuro Disorders
    • 15.5.4. Autoimmune Diseases
    • 15.5.5. Cancer
    • 15.5.6. GvHD
    • 15.5.7. Pulmonary Diseases
    • 15.5.8. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Type
    • 15.7.3. By Source of Isolation
    • 15.7.4. By Indication
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2021
  • 16.3. Company Profiles
    • 16.3.1. Thermo Fisher Scientific, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Cytiva (Danaher Corporation)
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. FUJIFILM Irvine Scientific (FUJIFILM Corporation)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck KGaA
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Lonza Group Ltd.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. STEMCELL Technologies, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Takara Bio, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Sartorius AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Miltenyi Biotec GmbH
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. PromoCell GmbH
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview